Paper · 3201241
Novel regulators of bone formation: molecular clones and activities.
Wozney JM and 7 others. Science, 1988. Cited by 3,311 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Novel regulators of bone formation: molecular clones and activities. Papers, record 3201241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3201241
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Growth Substances | Major topic |
| Osteogenesis | Major topic |
| Proteins | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Bone Morphogenetic Proteins | |
| Cartilage | |
| Cell Line | |
| DNA | |
| Humans | |
| Molecular Sequence Data | |
| Recombinant Proteins | |
| Sequence Homology, Nucleic Acid | |
| Transforming Growth Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by827
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,311 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,884,980 | Hydrogel-Based BMP-2 Delivery for Bone Regeneration: From Material Control to Biological and Translational Evaluation. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42884980 | PubMed |
| 42,846,932 | Dynamic microenvironments for bone organoids: spatiotemporal regulation of angiogenic-osteogenic coupling through advanced hydrogel design. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42846932 | PubMed |
| 42,755,579 | Single-cell RNA sequencing reveals a pro-fibrotic epithelial subpopulation contributing to endometrial dysfunction in polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42755579 | PubMed |
| 42,699,681 | BMP-2-driven osteo-organoid formation retains key osteogenic-support features and promotes bone repair following total-body irradiation. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42699681 | PubMed |
| 42,564,761 | Multiomics Integration Reveals Coexpression Regulatory Networks in Osteoporosis and Osteosarcoma. | Int J Genomics | 2026 | https://conductscience.org/library/papers/42564761 | PubMed |
| 42,018,556 | In vivo mouse model of calcific myonecrosis induced by injury. | PLoS One | 2026 | https://conductscience.org/library/papers/42018556 | PubMed |
| 41,803,087 | PRMT6 is required for initiating and amplifying macrophage-induced inflammation in heterotopic ossification by increasing CCL2 expression. | Bone Res | 2026 | https://conductscience.org/library/papers/41803087 | PubMed |
| 41,741,664 | The bone marrow microenvironment during homeostasis and after myeloablation. | J Bone Miner Metab | 2026 | https://conductscience.org/library/papers/41741664 | PubMed |
| 41,416,064 | Evaluating Clinical Outcomes of Recombinant Human Bone Morphogenetic Protein-2 in the Treatment of Subchondral Plate Damage Associated With Ankle Osteochondral Lesions. | Foot Ankle Orthop | 2025 | https://conductscience.org/library/papers/41416064 | PubMed |
| 41,273,147 | Growth and Developmental Processes Alternate During Larval Development of Atlantic Herring. | Evol Dev | 2025 | https://conductscience.org/library/papers/41273147 | PubMed |
1 to 10 of 827
See all 827 cited byGenes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BMP1 | 649 | Swiss-Prot's references | https://conductscience.org/library/genes/649 | NCBI Gene |
| BMP2 | 650 | Swiss-Prot's references | https://conductscience.org/library/genes/650 | NCBI Gene |
| BMP3 | 651 | Swiss-Prot's references | https://conductscience.org/library/genes/651 | NCBI Gene |
| BMP4 | 652 | Swiss-Prot's references | https://conductscience.org/library/genes/652 | NCBI Gene |
| TGFB1 | 7,040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data4
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3201241
GET https://conductscience.org/api/papers/v1/3201241/cited_by?page=2